These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 4943397)

  • 21. Lamprene: first results of treatment in the Netherlands in a group of 6 leprosy patients.
    Hogerzeil LM
    Dermatologica; 1971; 143(6):339-44. PubMed ID: 5150817
    [No Abstract]   [Full Text] [Related]  

  • 22. Editorial: Prevention of leprosy.
    J Trop Med Hyg; 1974 Mar; 77(3):49. PubMed ID: 4598138
    [No Abstract]   [Full Text] [Related]  

  • 23. Leprosy (Hansen's disease).
    Brazin SA
    Otolaryngol Clin North Am; 1982 Aug; 15(3):597-611. PubMed ID: 6752824
    [No Abstract]   [Full Text] [Related]  

  • 24. [New methods of experimental chemotherapy in leprosy].
    Wagner WH
    Hautarzt; 1969 Sep; 20(9):385-9. PubMed ID: 4191849
    [No Abstract]   [Full Text] [Related]  

  • 25. [. 663 (G 30320 "Geigy"), a new chemotherapeutic agent against leprosy].
    Vischer WA
    Schweiz Med Wochenschr; 1967 Mar; 97(10):308. PubMed ID: 5585384
    [No Abstract]   [Full Text] [Related]  

  • 26. The bases of chemotherapy and immunosuppressive therapy in leprosy.
    Browne SG
    Int J Lepr Other Mycobact Dis; 1971; 39(2):406-12. PubMed ID: 4948083
    [No Abstract]   [Full Text] [Related]  

  • 27. [Current state of thalidomide treatment of leprosy and leprosy reaction].
    Sheskin J; Sagher F
    Arch Klin Exp Dermatol; 1970; 237(1):312-6. PubMed ID: 4906813
    [No Abstract]   [Full Text] [Related]  

  • 28. The impact of experimental human leprosy in the mouse on leprosy research.
    Rees RJ
    Int J Lepr Other Mycobact Dis; 1971; 39(2):201-15. PubMed ID: 4948076
    [No Abstract]   [Full Text] [Related]  

  • 29. Controlled drug trial of B.663 compared with DDS. Preliminary (48 week) report.
    Tolentino JG; Rodriquez JN; Abalos RM
    Int J Lepr Other Mycobact Dis; 1971; 39(3):738-41. PubMed ID: 5169924
    [No Abstract]   [Full Text] [Related]  

  • 30. Primary dapsone-resistant leprosy in Cebu, Philippines.
    Guinto RS; Cellona RV; Fajardo TT; de la Cruz EC
    Int J Lepr Other Mycobact Dis; 1981 Dec; 49(4):427-30. PubMed ID: 7042607
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Summary of recent abstracts. 8. Leprosy.
    Browne SG
    Trop Dis Bull; 1972 Sep; 69(9):863-71. PubMed ID: 4562257
    [No Abstract]   [Full Text] [Related]  

  • 32. [Clinical and paraclinical aspects of secondary drug resistance to 4-4' diaminodiphenylsulfone in a population of leprosy patients in Bamako, Republic of Mali].
    Baquillon G; Ferracci C; Diallo J; Saint-Andreé P; Pattyn SR
    Acta Leprol; 1981; 85():40-52. PubMed ID: 6805234
    [No Abstract]   [Full Text] [Related]  

  • 33. Clofazimine in leprosy.
    Browne SG
    Br Med J; 1972 Feb; 1(5798):506-7. PubMed ID: 4550304
    [No Abstract]   [Full Text] [Related]  

  • 34. Efficacy of clofazimine in the prophylaxis and suppression of reactive phases of lepromatous leprosy.
    Karat AB; Jeevaratnam A; Karat S; Rao PS
    Int J Lepr Other Mycobact Dis; 1971; 39(4):838-41. PubMed ID: 5170472
    [No Abstract]   [Full Text] [Related]  

  • 35. [Prevalence of dapsone-resistant leprosy in Burundi. Temporary results].
    Bourland J; Van Loo L; Pattyn SR
    Acta Leprol; 1982; (86-87):29-33. PubMed ID: 6815995
    [No Abstract]   [Full Text] [Related]  

  • 36. [Current treatment of leprosy in the Malta pavilion of the Hôpital Saint-Louis].
    Pennec J
    Ann Med Interne (Paris); 1974; 125(6-7):561-4. PubMed ID: 4440971
    [No Abstract]   [Full Text] [Related]  

  • 37. Leprosy reactional states and their treatment.
    Jolliffe DS
    Br J Dermatol; 1977 Sep; 97(3):345-52. PubMed ID: 336075
    [No Abstract]   [Full Text] [Related]  

  • 38. Chemotherapy of leprosy.
    Leiker DL
    Int J Lepr Other Mycobact Dis; 1971; 39(2):462-6. PubMed ID: 4948084
    [No Abstract]   [Full Text] [Related]  

  • 39. [Incorporation of thalidomide to the therapeutic arsenal of Hansen's disease (award of the Spanish Academy of Dermatology 1968)].
    Sheskin J
    Actas Dermosifiliogr; 1969; 60(3):57-72. PubMed ID: 5800285
    [No Abstract]   [Full Text] [Related]  

  • 40. Secondary dapsone-resistant leprosy in Shanghai Municipality.
    Ji BH; Chen JK; Zhang JL; Hou YH; Ni GX; Zhang RB
    Lepr Rev; 1983 Sep; 54(3):197-202. PubMed ID: 6355724
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.